Status
Conditions
Treatments
About
The primary objective of this clinical trial will be to compare overall colorectal cancer (CRC) screening participation between an active choice (fecal immunochemical test [FIT] or colonoscopy) and a sequential choice (FIT offered first, then colonoscoscopy offered in those still unscreened) arm. Secondarily, we will (1) compare the proportions of FIT vs. colonoscopy per arm, (2) compare active choice vs FIT only in the initial 3 months of the study, (3) characterize changes in physician knowledge and attitudes regarding CRC screening before and after an educational seminar delivered at the launch of the initiative, (4) characterize perceptions regarding the effect of the intervention on clinical practices, and (5) compare detection rates of CRC, adenomas and SSLs per arm, and the operational results of the outreach program across arms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adults 45-75 years of age not up to date with CRC screening, and without precancerous polyp history (i.e. not in post-polypectomy surveillance; ascertained based on problem list or colonoscopy results letter).
The assessment of screening status will happen monthly, on a rolling basis.
Definition of being up to date with CRC screening includes any one of the following:
i) FIT or guaiac-FOBT within 1 year, OR
ii) Colonoscopy within 10 years, OR
iii) Sigmoidoscopy within 5 years, OR
iv) CT colonography within 5 years, OR
v) Cologuard within 3 years
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
5,000 participants in 2 patient groups
Loading...
Central trial contact
Uri Ladabaum, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal